World Organization for the Development and Manufacturing of Small Molecule Contracts 2021 – Key Drivers and Constraints – ResearchAndMarkets.com


DUBLIN – (COMMERCIAL THREAD) – The “Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2021” report has been added to ResearchAndMarkets.com offer.

This study presents the overall revenue forecast for the market and segments of the global Small Molecule Contract Development and Manufacturing Organization (CDMO) industry. It highlights the main growth opportunities for small molecule CDMOs based on the main evolution of their business models and strategic approaches as well as those of pharmaceutical sponsors.

The study segments the market into two categories based on the type of product:

  • Manufacture of active pharmaceutical ingredients (API) (API / drug substance) and manufacture of finished dosage forms (FDF) (FDF / drug product).

    • API is further segmented into innovative and generic APIs, while FDF is segmented into oral, semi-solid / liquid and injectable forms.

The market forecast in this report is for 2020-2026, capturing key market developments such as capacity expansions, mergers, acquisitions, and expansion of service offerings that are expected to affect the overall growth of the Small-Scale CDMO Market. molecules.

Other discussions in the study include:

  • The impact of strategic imperatives on the industry

  • Growth drivers and constraints

  • Comprehensive information on the competitive landscape

  • Revenue share estimates for major market players

  • Strategic analysis of changes in the market for service offers and economic models

  • Growth opportunities for small molecule CDMOs

Main topics covered:

1. Strategic imperatives

2. Analysis of growth opportunities

  • Scope of the analysis

  • Market segmentation by product type

  • Market segmentation by type of service

  • Key Competitors

  • Key growth indicators

  • Growth drivers for the small molecule CDMO market

  • Growth constraints for the small molecule CDMO market

  • Forecasting framework – Market sizing

  • Forecasting methodology

  • Forecast assumptions and considerations

  • Revenue forecast

  • Revenue forecast analysis

  • Revenue forecast by product type

  • Analysis of revenue forecasts by product type

  • Revenue forecast by region

  • Revenue forecast analysis by region

  • Main relocation initiatives for pharmaceutical manufacturing

  • Breakdown of revenues by type of service

  • Analysis of the distribution of revenues by type of service

  • Competitive environment

  • Market share, total pharmaceutical CDMO market

3. Growth environment

  • Small Molecules Market Outlook – Key Segment Share

  • Comparison between approvals of small molecules and biologics

  • Expanding the CDMO Value Chain – Complete End-to-End Offering for Small Molecules and Biologics

  • Evolution of the CDMO business model – Transactional to strategic partnerships

  • Key growth trends shaping the small molecule CDMO industry

  • Key Consolidation and Expansion Steps in the Small Molecule CDMO Industry

  • Key expansion initiatives by small molecule CDMOs

4. Growth Opportunity Analysis, Small Molecule CDMO Market – API

  • Key Growth Indicators, Small Molecule CDMO Market – API

  • Revenue Forecast, Small Molecule CDMO Market – API

  • Revenue forecast by Product Type, Small Molecule CDMO Market – API

  • Revenue Forecast Analysis by Product Type, Small Molecule CDMO Market – API

5. Growth Opportunity Analysis, Small Molecule CDMO Market – FDF

  • Key Growth Indicators, Small Molecule CDMO Market – FDF

  • Revenue Forecast, Small Molecule CDMO Market – FDF

  • Revenue Forecast by Product Type, Small Molecule CDMO Market – FDF

  • Revenue Forecast Analysis by Product Type, Small Molecule CDMO Market – FDF

6. Universe of growth opportunities

  • Growth opportunity 1 – Capacity expansion in the United States and Europe for relocation and proximity manufacturing

  • Growth Opportunity 2 – Phase-Tailored Manufacturing Services for High Potency Drugs

  • Growth opportunity 3 – Focus on emerging small biopharmaceutical companies to develop innovative small molecules

  • Growth Opportunity 4 – Integrated Drug-Device Combination Product Services for New and Existing Drugs

7. Next steps

8. List of exhibitions

For more information on this report, visit https://www.researchandmarkets.com/r/xqw2ry

About Warren Dockery

Check Also

Thin Film Transistor Liquid Crystal Display Market Recent Developments and Emerging Trends – Instant Interview

Global thin film transistor liquid crystal display market is expected to proliferate from 2022 to …

Leave a Reply

Your email address will not be published.